Program Schedule

203
Clostridium difficile Infection: Epidemiology, Presentation, Treatment

Saturday, October 11, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Learning Objectives:

-

Target Audience: Academicians

Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID

Presentations:
Extraintestinal Clostridium difficile infections: A Single Center Experience
Arjun Gupta, MBBS ; Robin Patel, MD, FIDSA, FRCP(C), D(ABMM), FACP, F(AAM) ; Larry M. Baddour, MD ; Darrell Pardi, MD, MS ; Sahil Khanna, MBBS, MS
Posters
  • EICDI poster_Gupta.pdf (196.7 kB)
  • US Costs and Outcomes Associated with Clostridium difficile Infections: a Systematic Literature Review, Meta-analysis, and Mathematical Model
    Marin Schweizer, PhD ; Richard E. Nelson, PhD ; Matthew Samore, MD ; Scott D Nelson, PharmD ; Karim Khader, PhD ; Rachel Slayton, PhD, MPH ; John Jernigan, MD, MS ; Hsiu-Yin Chiang, PhD, MS ; Margaret Chorazy, Ph.D, M.P.H ; Loreen a. Herwaldt, MD, FIDSA, FSHEA ; Daniel J. Diekema, MD, FIDSA, FSHEA ; Michelle Formanek, MS ; Ashish Malhotra, MBBS MSCI ; Amy Blevins, MALS ; Melissa Ward, MS ; Eli Perencevich, MD, MS, FIDSA, FSHEA
    Posters
  • C dif poster final.gif (451.8 kB)
  • Ertapenem is Associated with an Increased Risk of Clostridium difficile Infections Among Surgical Patients
    Seungwon Lee, MPH ; Priya Prasad, MPH ; Matthew Lin, MD ; Susan Garritson, RN ; Amy Nichols, RN ; Catherine Liu, MD
    Risk Factors for Hospital-Acquired Clostridium difficile
    Bryan Knepper, MPH, MSc ; Connie Price, MD
    The relationship of Bristol Stool Scale to Clostridium difficile infection
    Daniel Caroff, MD ; Paul Edelstein, MD ; Keith Hamilton, MD ; David Pegues, MD, FIDSA, FSHEA
    Diagnostic Accuracy of Loop-Mediated Isothermal DNA Amplification (LAMP) Assay for Detection of Clostridium difficile Infection (CDI): a Meta-Analysis
    Aaron Lloyd, BS ; Priyaleela Thota, MD ; Chaitanya Pant, MD ; Vinay Pasupuleti, MD, PhD ; Adrian V. Hernandez, M.D., Ph.D. ; Curtis J. Donskey, MD ; Abhishek Deshpande, MD, PhD
    Accuracy of Healthcare Facility-Onset Clostridium difficile Classification
    Regan Trappler, RN, BSN, MPH ; Karen Torres, RN, BSN, CIC ; Ian Seemungal, MD ; Anita Majette-Cain, RN, BSN ; Rohit Modak, MD, MBA
    The Incidence of Clostridium difficile Infection in Hospitalized Patients with Cystic Fibrosis in the United States
    Abhishek Deshpande, MD, PhD ; Chaitanya Pant, MD ; Mojtaba Olyaee, MD ; Thomas Sferra, MD
    Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
    Vanessa Stevens, PhD ; Karim Khader, PhD ; Richard E. Nelson, PhD ; Makoto Jones, MD, MS ; Michael Rubin, MD, PhD ; Matthew Samore, MD
    Posters
  • CDI LOS IDWEEK 2014.pdf (472.9 kB)
  • The Impact of Obesity of Clostidium difficile Recurrence
    Uvette Lou, BS ; Kalpana Gupta, MD, MPH ; Judith Strymish, MD ; Errol Baker, PhD ; Donald Smith, RPH ; Nahid Bhadelia, MD, MA
    PREVENTON OF CLOSTRIDIUM DIFFICILE INFECTION: A HUMAN FACTORS AND SYSTEMS ENGINEERING APPROACH
    Eric Yanke, MD ; Pascale Carayon, PHD ; Caroline Zellmer ; Helene Moriarty, RN, PhD ; Nasia Safdar, MD, PhD
    Clinical Characteristics of Relapses AND Reinfections in Clostridium difficile Infection 
    Jieun Kim, MD ; Mi-Ran Seo ; Jung-Oak Kang, MD, PhD ; Yeonjae Kim, MD ; Seung-Pyo Hong ; Hyunjoo Pai, MD
    A Retrospective Study Comparing Outcomes of Present on Admission Clostridium difficile Infection (CDI) versus Non-present on Admission CDI at a Tertiary-care Hospital in Detroit
    Reda A. Awali, MD, MPH ; Iqbaljit Singh, MD ; Sandhya Narukonda, MD ; Sruthi Gaddipati, MD ; Bharat Marwaha, MD ; Keith Kaye, MD, MPH ; Teena Chopra, MD, MPH
    Low Incidence Of Clostridium Difficile Infection (CDI) in Patients Treated with  Community Outpatient Parenteral Antimicrobial Therapy (CoPAT)
    Ken Koon Wong, MD ; Thomas G. Fraser, MD, FSHEA ; Nabin Shrestha, MD, MPH, FIDSA ; Abhishek Deshpande, M.D., Ph.D.
    Epidemiology of Clostridium difficile Infection in an Integrated Healthcare System Over a 10-year Period
    Bert K. Lopansri, MD ; Rajesh Mehta, RPh, MS ; Edward Stenehjem, MD MSc ; Kristin Dascomb, MD, PhD ; Julia Shumway, MPH ; Stanley Giddings, MD ; Andrew Pavia, MD, FIDSA, FSHEA ; John Burke, MD
    Clostridium difficile Strains Colonizing Long-Term Care Facility (LTCF) Residents are Similar to Strains Causing Infection in both LTCF and Hospital Patients Suggesting a Shared Continuum of Transmission
    Susan M. Pacheco, MD ; Curtis J. Donskey, MD ; Matthew Samore, MD ; Jeanmarie Mayer, MD ; Nimalie Stone, MD ; Carolyn Gould, MD ; L. Clifford Mcdonald, MD, FACP, FSHEA ; Laurica a. Petrella, BS ; Susan Sambol, BS, MT ; Annette Jencson, BS, MT, CIC ; Venkata Sunkesula, MD, MS ; Dale Gerding, MD
    Antibiotic Use Patterns in a Population with Long Term Care-Onset C. difficile Infection Developing after Recent Hospitalization
    Christina Felsen, MPH ; Gail Quinlan, RN, MSN ; Cathleen Concannon, MPH ; Anita Gellert, RN ; Deborah Nelson, MSN, RN ; Rebecca Tsay, MPH, MLS ; Ghinwa Dumyati, MD ; Elizabeth Dodds-Ashley, PharmD, MHS
    Posters
  • ID Week Poster_Felsen.pdf (557.1 kB)
  • Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
    Jessica Cohen, MPH ; Nicole Gregoricus, MSPH ; Monica M. Farley, MD ; Rebecca Perlmutter, MPH ; Stacy M. Holzbauer, DVM, MPH ; Ghinwa Dumyati, MD ; Zintars G. Beldavs, MS ; Ashley Lyn Paulick, BS ; Jan Vinje, PhD ; Brandi Limbago, PhD ; Fernanda C. Lessa, MD
    Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
    Ghinwa Dumyati, MD ; Rebecca Tsay, MPH, MLS ; Deborah Nelson, MSN, RN
    Clostridium difficile Infection Related Emergency Department Visits in the United States 2006-2009
    Abhishek Deshpande, M.D., Ph.D. ; Chaitanya Pant, MD ; Mojtaba Olyaee, MD ; Thomas Sferra, MD
    Risk Factors for Community-Associated Clostridium difficile Infection in Children
    Jonathan Crews, MD ; Lauren Anderson, MD ; Kim Waller, PhD ; Michael Swartz, PhD ; Herbert Dupont, MD, FIDSA ; Jeffrey Starke, MD, FIDSA
    Are Hospital Floors an Underappreciated Reservoir for Transmission of Clostridium difficile and Methicillin-Resistant Staphylococcus aureus?
    Abhishek Deshpande, MD, PhD ; Jennifer Cadnum, B.S. ; Dennis Fertelli ; Brett Sitzlar, B.S. ; Priyaleela Thota, MD ; Thriveen Mana, M.S., MBA ; Annette Jencson, BSMT(ASCP)SM, CIC ; Erica Pozwick ; Holly Doehring ; Jizal Seikali, BS ; Curtis J. Donskey, MD
    Role of Metronidazole vs. Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs. non-NAP1 Disease
    Yanina Dubrovskaya, PharmD ; Justin Siegfried, PharmD ; Thomas Flagiello ; Marco R. Scipione, PharmD ; Donald Chen, MD ; Michael Phillips, MD ; John Papadopoulos, PharmD ; Amar Safdar, MD
    Posters
  • CDI IDSA Poster 10022014.pdf (338.7 kB)
  • Retrospective Comparision of Oral Vancomycin Capsules Versus Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
    Rania Saleh, MD ; Sharon Sam, PharmD ; Lisa Russell, MD ; Paiboon Jungsuwadee, PhD ; Diane Cluxton, PharmD Candidate ; Alex Mersch, PharmD Candidate
    Results of a Treatment Protocol Encouraging First-Line Use of Fidaxomicin for Select Patients with Clostridium difficile Infection (CDI)
    Bhagyashri Navalkele, MD ; Gemma Downham, MPH, CIC ; Kevin Haynes, PharmD, MSCE ; Jason Gallagher, PharmD, FCCP, BCPS ; Joseph Reilly, PharmD, MSCE ; Manish Trivedi, MD
    Posters
  • IDSA poster CDI.pdf (1.1 MB)
  • Fecal Microbiota Transplant for the Treatment of Recurrent Clostridium difficile Infection via Encapsulated Cryopreserved Concentrated Fecally Derived Bacteria: A Cohort Review
    Nimit Saraiya, MD ; Kaitlin Poeth, MD ; Bruce Hirsch, MD ; Marcia Epstein, MD ; Rebecca Schwartz, PhD ; Gerard Honig, PhD
    Posters
  • 1654_IDWPOSTER.pdf (4.0 MB)
  • Lack of Adherence to SHEA-IDSA Treatment Guidelines for Severe Clostridium difficile Infection is Associated with Increased Mortality
    Ishan Patel ; Manida Wungjiranirun, MD ; Thimmaiah Theethira, MD ; Javier Villafuerte, MD ; Daniel Leffler, MD, MS ; Ciaran Kelly, MD
    ONE CASE OF PEDIATRIC SEVEREPDEUDOMEMBRANOUS ENTERITIS TREATED WITH FECAL MICROBIOTA TRANSPLANTATION AND LITERATURE REVIEW
    Yongmei Xiao, M.D. ; Jiayi Wang ; Yanran Che ; Haifeng Liu ; Hong Zhang ; Yongchen Yang ; Zhihong Hu ; Ting Zhang, M.D., Ph.D.
    Who Seeks a Fecal Microbiota Transplant for Recurrent C. difficile Infection?: Patient Profile of the PUNCH CD Study
    Robert Orenstein, DO ; Erik Dubberke, MD, MSPH ; Cheryl Griesbach, RN ; Mary Kay Sobcinski, RN, MHA
    C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
    Marya D. Zilberberg, MD, MPH ; Andrew F. Shorr, MD, MPH ; Scott Micek, PharmD ; Marin Kollef, MD
    Relapse versus Reinfection. Evaluation of Clostridium difficile Isolates from Incident and Recurrent Infections, Minnesota 2009-2011
    Tory Whitten, MPH ; Selina Jawahir, BS ; David Boxrud, MS ; Stacy M. Holzbauer, DVM, MPH
    Posters
  • IDWeek_Whitten.pdf (379.9 kB)
  • Risk of Recurrent Clostridium difficile Infection: Impact of Diagnostics and Treatment
    Sujan C. Reddy, MD ; Olivia M. Almendares, MSPH ; Wendy Baughman, MSPH ; Fernanda C. Lessa, MD ; Monica M. Farley, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek